Literature DB >> 29457205

Growth Hormone Therapy and Lipid Profile.

Rajni Sharma1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29457205     DOI： 10.1007/s12098-018-2638-8

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  16 in total

1.  Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society.

Authors:  P E Clayton; S Cianfarani; P Czernichow; G Johannsson; R Rapaport; A Rogol
Journal:  J Clin Endocrinol Metab       Date:  2007-01-02       Impact factor: 5.958

2.  Lipid patterns in treated growth hormone deficient children vs. short stature controls.

Authors:  Christy Foster; Amy Burton; Jenni Scholl; Mary Lauren Scott; Victoria Gunter; Kenneth McCormick
Journal:  J Pediatr Endocrinol Metab       Date:  2014-09       Impact factor: 1.634

Review 3.  Metabolic alterations in paediatric GH deficiency.

Authors:  Juliane Rothermel; Thomas Reinehr
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2016-11-04       Impact factor: 4.690

4.  Effects of Growth Hormone Treatment on Lipid Profiles.

Authors:  Toshihide Kubo; Mahoko Furujo; Kyohei Takahashi; Yuki Hyodo; Hiroki Tsuchiya; Mariko Hattori; Shoko Fujinaga; Kenji Urayama
Journal:  Indian J Pediatr       Date:  2017-11-11       Impact factor: 1.967

5.  Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy.

Authors:  Kim M J A Claessen; Natasha M Appelman-Dijkstra; Desirée M M M Adoptie; Ferdinand Roelfsema; Johannes W A Smit; Nienke R Biermasz; Alberto M Pereira
Journal:  J Clin Endocrinol Metab       Date:  2012-11-15       Impact factor: 5.958

6.  Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study.

Authors:  Jean-Claude Carel; Emmanuel Ecosse; Fabienne Landier; Djamila Meguellati-Hakkas; Florentia Kaguelidou; Grégoire Rey; Joël Coste
Journal:  J Clin Endocrinol Metab       Date:  2012-01-11       Impact factor: 5.958

7.  Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.

Authors:  T Sas; P Mulder; A Hokken-Koelega
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

8.  Growth hormone reduces plasma cholesterol in LDL receptor-deficient mice.

Authors:  M Rudling; B Angelin
Journal:  FASEB J       Date:  2001-06       Impact factor: 5.191

9.  Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.

Authors:  Mariacarolina Salerno; Valentina Esposito; Letizia Spinelli; Carolina Di Somma; Vincenzo Farina; Stefania Muzzica; Laura Tanturri de Horatio; Gaetano Lombardi; Annamaria Colao
Journal:  Clin Endocrinol (Oxf)       Date:  2004-05       Impact factor: 3.478

10.  Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials.

Authors:  Patrick Maison; Simon Griffin; Marc Nicoue-Beglah; Nabila Haddad; Beverley Balkau; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958
View more
  2 in total

1.  Untargeted LC/MS-Based Metabolic Phenotyping of Hypopituitarism in Young Males.

Authors:  Yuwen Zhang; Shouyue Sun; Ming Wang; Wenjuan Yu; Peizhan Chen; Fei Yuan; Xuqian Fang
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

2.  Human growth hormone level decreased in women aged <60 years but increased in men aged >50 years.

Authors:  Ximei Wang; Shuyi Wang; Huan Wu; Mingfei Jiang; Hui Xue; Yangqi Zhu; Chenxu Wang; Xiaojuan Zha; Yufeng Wen
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.